\-\ Texto\\:\\ \ \(0\)\
\-\ an\\ intradural\\ extramedullary\\ mass\\ is\\ seen\\ at\\ the\\ t2\\ level\\ measuring\\ 1\\.2\\ cm\\ ap\\ x\\ 1\\.1\\ cm\\ transverse\\ x\\ 1\\.7\\ cm\\ craniocaudad\\.\\ this\\ mass\\ causes\\ mild\\ compression\\ and\\ leftward\\ shift\\ of\\ the\\ spinal\\ cord\\.\\ subtle\\ hyperintense\\ t2\\ signal\\ abnormality\\ is\\ noted\\ within\\ the\\ mass\\,\\ and\\ uniformly\\ enhances\\ following\\ gadolinium\\ dtpa\\.\\ there\\ is\\ a\\ no\\ dural\\ tail\\.\\ the\\ spinal\\ cord\\ is\\ normal\\ in\\ signal\\.\\ no\\ neural\\ foraminal\\ extension\\ is\\ seen\\.\ \(0\)\
\-\ intradural\\ extramedullary\\ meningioma\\.\ \(0\)\
\-\ intradural\\ extramedullary\\ neoplasms\\:\ \(0\)\
\-\ schwannoma\ \(67\)\
\-\ neurofibroma\ \(78\)\
\-\ ganglioneuroma\ \(11\)\
\-\ meningioma\ \(167\)\
\-\ epidermoid\ \(89\)\
\-\ dermoid\ \(313\)\
\-\ metastasis\ \(206\)\
\-\ 56\\ yo\\ male\\ with\\ 24\\ month\\ history\\ of\\ gradually\\ worsening\\ upper\\ back\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ extramedullary\\:\\ 0\\.40020988475269836\ \(0\)\
\-\ intradural\\:\\ 0\\.3961832143733391\ \(0\)\
\-\ cm\\:\\ 0\\.20440037305458492\ \(0\)\
\-\ meningioma\\:\\ 0\\.17779162762312675\ \(0\)\
\-\ cord\\:\\ 0\\.17587890025639513\ \(0\)\
\-\ spinal\\:\\ 0\\.16847747490189618\ \(0\)\
\-\ is\\:\\ 0\\.1624450787079781\ \(0\)\
\-\ craniocaudad\\:\\ 0\\.1608921754382755\ \(0\)\
\-\ leftward\\:\\ 0\\.1542692150538458\ \(0\)\
\-\ uniformly\\:\\ 0\\.1464766234480276\ \(0\)\
\-\ ganglioneuroma\\:\\ 0\\.14183585225905737\ \(0\)\
\-\ dtpa\\:\\ 0\\.1398536630635979\ \(0\)\
\-\ t2\\:\\ 0\\.13650804352753956\ \(0\)\
\-\ mass\\:\\ 0\\.13594627173612428\ \(0\)\
\-\ signal\\:\\ 0\\.13450167915414074\ \(0\)\
\-\ foraminal\\:\\ 0\\.12451363686012396\ \(0\)\
\-\ gradually\\:\\ 0\\.12362851411628846\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.11732307509591199\ \(0\)\
\-\ tail\\:\\ 0\\.11700555373185875\ \(0\)\
\-\ seen\\:\\ 0\\.11170484639174336\ \(0\)\
\-\ 56\\:\\ 0\\.1107875594599367\ \(0\)\
\-\ neoplasms\\:\\ 0\\.110555185585827\ \(0\)\
\-\ neural\\:\\ 0\\.10987324759500375\ \(0\)\
\-\ dural\\:\\ 0\\.10527724982562567\ \(0\)\
\-\ enhances\\:\\ 0\\.10457219093707033\ \(0\)\
\-\ shift\\:\\ 0\\.10422842698862914\ \(0\)\
\-\ epidermoid\\:\\ 0\\.10306812039302223\ \(0\)\
\-\ subtle\\:\\ 0\\.10227725531624653\ \(0\)\
\-\ schwannoma\\:\\ 0\\.10166552752838481\ \(0\)\
\-\ dermoid\\:\\ 0\\.1002105815955274\ \(0\)\
\-\ gadolinium\\:\\ 0\\.0988508003083005\ \(0\)\
\-\ the\\:\\ 0\\.09468796847190332\ \(0\)\
\-\ hyperintense\\:\\ 0\\.09436858576052395\ \(0\)\
\-\ measuring\\:\\ 0\\.09177802425403617\ \(0\)\
\-\ transverse\\:\\ 0\\.09140663500328021\ \(0\)\
\-\ worsening\\:\\ 0\\.09059449186374283\ \(0\)\
\-\ causes\\:\\ 0\\.08964310062400334\ \(0\)\
\-\ metastasis\\:\\ 0\\.08695072943480976\ \(0\)\
\-\ compression\\:\\ 0\\.08687658587903356\ \(0\)\
\-\ abnormality\\:\\ 0\\.08629276521651788\ \(0\)\
\-\ ap\\:\\ 0\\.08517210380941101\ \(0\)\
\-\ 24\\:\\ 0\\.08410875424427451\ \(0\)\
\-\ extension\\:\\ 0\\.08397957839191808\ \(0\)\
\-\ back\\:\\ 0\\.07912103301028572\ \(0\)\
\-\ no\\:\\ 0\\.07715753975598788\ \(0\)\
\-\ yo\\:\\ 0\\.07411645233361829\ \(0\)\
\-\ month\\:\\ 0\\.07216707499671567\ \(0\)\
\-\ level\\:\\ 0\\.07166243769922738\ \(0\)\
\-\ following\\:\\ 0\\.07116975571648279\ \(0\)\
\-\ mild\\:\\ 0\\.06725083957707037\ \(0\)\
\-\ upper\\:\\ 0\\.063396735943375\ \(0\)\
\-\ noted\\:\\ 0\\.0629001323002228\ \(0\)\
\-\ within\\:\\ 0\\.05463964792158064\ \(0\)\
\-\ male\\:\\ 0\\.05282089004705189\ \(0\)\
\-\ and\\:\\ 0\\.04902896322715341\ \(0\)\
\-\ normal\\:\\ 0\\.048437897360254764\ \(0\)\
\-\ there\\:\\ 0\\.04720452009141615\ \(0\)\
\-\ of\\:\\ 0\\.04643271020866898\ \(0\)\
\-\ an\\:\\ 0\\.045365646697539695\ \(0\)\
\-\ history\\:\\ 0\\.045325458771279796\ \(0\)\
\-\ at\\:\\ 0\\.04480996204689909\ \(0\)\
\-\ pain\\:\\ 0\\.04245198850349671\ \(0\)\
\-\ this\\:\\ 0\\.04076514124306042\ \(0\)\
\-\ in\\:\\ 0\\.029512551417878983\ \(0\)\
\-\ with\\:\\ 0\\.023230226870977175\ \(0\)\
